BAYER AG-SPONSORED ADR Share Price Today: Live Updates & Key Insights

BAYER AG-SPONSORED ADR share price today is $null, up null%. The stock opened at $null against the previous close of $null, with an intraday high of $null and low of $null.

BAYER AG-SPONSORED ADR Share Price Chart

BAYER AG-SPONSORED ADR

us-stock
To Invest in {{usstockname}}
us-stock

BAYER AG-SPONSORED ADR Share Price Performance

$null null(null%) null at 23 Mar 2026 12:09 PM Drug Manufacturers - General
Lowest Today 0.00
Highest Today 0.00
Today’s Open 0.00
Prev. Close 0.00
52 Week High 14.85
52 Week Low 5.35
Day’s Range: Low null High null
52-Week Range: Low 5.35 High 14.85
1 day return -
1 Week return -
1 month return -
3 month return -
6 month return -
1 year return -
3 year return -
5 year return -
10 year return -

BAYER AG-SPONSORED ADR Institutional Holdings

BAYER AG-SPONSORED ADR Market Status

BAYER AG-SPONSORED ADR Fundamentals

Market Cap 43395.46 M

PB Ratio 1.4493

PE Ratio 0.0

Enterprise Value 76100.21 M

Total Assets 104541.00 M

Volume null

BAYER AG-SPONSORED ADR Company Financials

Annual Revenue FY23:47775000000 47775.0M, FY22:50739000000 50739.0M, FY21:44081000000 44081.0M, FY20:41400000000 41400.0M, FY19:43545000000 43545.0M

Annual Profit FY23:27744000000 27744.0M, FY22:30868000000 30868.0M, FY21:27265000000 27265.0M, FY20:22262000000 22262.0M, FY19:26078000000 26078.0M

Annual Net worth FY23:-3667000000 -3667.0M, FY22:4150000000 4150.0M, FY21:1000000000 1000.0M, FY20:-15561000000 -15561.0M, FY19:2430000000 2430.0M

Quarterly Revenue Q3/2025:9660000000 9660.0M, Q2/2025:10739000000 10739.0M, Q1/2025:13738000000 13738.0M, Q3/2024:9968000000 9968.0M, Q2/2024:11144000000 11144.0M

Quarterly Profit Q3/2025:5353000000 5353.0M, Q2/2025:6375000000 6375.0M, Q1/2025:8113000000 8113.0M, Q3/2024:4878000000 4878.0M, Q2/2024:6150000000 6150.0M

Quarterly Net worth Q3/2025:-963000000 -963.0M, Q2/2025:-199000000 -199.0M, Q1/2025:1299000000 1299.0M, Q3/2024:-4183000000 -4183.0M, Q2/2024:-34000000 -34.0M

About BAYER AG-SPONSORED ADR & investment objective

Company Information Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment offers nonprescription over-the-counter medicines for self-medication and self-care; nutritional supplements; allergy, cough, and cold; dermatology; pain and cardiovascular risk prevention; and digestive health products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.

Organisation Drug Manufacturers - General

Employees 87280

Industry Drug Manufacturers - General

CEO Mr. William N. Anderson

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

BAYER AG-SPONSORED ADR FAQs

What is the share price of BAYER AG-SPONSORED ADR today?

The current share price of BAYER AG-SPONSORED ADR is $null.

Can I buy BAYER AG-SPONSORED ADR shares in India?

Yes, Indian investors can buy BAYER AG-SPONSORED ADR shares by opening an international trading and demat account with Motilal Oswal.

How to buy BAYER AG-SPONSORED ADR shares in India?

You can easily invest in BAYER AG-SPONSORED ADR shares from India by:

Can I buy fractional shares of BAYER AG-SPONSORED ADR?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of BAYER AG-SPONSORED ADR?

BAYER AG-SPONSORED ADR has a market cap of $43395.46 M.

In which sector does BAYER AG-SPONSORED ADR belong?

BAYER AG-SPONSORED ADR operates in the Drug Manufacturers - General sector.

What documents are required to invest in BAYER AG-SPONSORED ADR stocks?

To invest, you typically need:

What is the PE and PB ratio of BAYER AG-SPONSORED ADR?

The PE ratio of BAYER AG-SPONSORED ADR is N/A and the PB ratio is 1.45.